Market Cap: $19.57M
TI
TScan Therapeutics, Inc.
TCRX
NASDAQUSD
Market Cap: $19.57M
Analysts estimated TCRX earnings of $-0.22 per share this quarter (Q2). TCRX's actual earnings were $-0.23 per share.
TCRX EPS surprise of -5.02%Analysts estimated TCRX earnings of $-0.18 per share this quarter (Q1). TCRX's actual earnings were $-0.22 per share.
TCRX EPS surprise of -25.43%Analysts estimated TCRX earnings of $-0.25 per share this quarter (Q4). TCRX's actual earnings were $-0.18 per share.
TCRX EPS surprise of 26.83%Analysts estimated TCRX earnings of $-0.30 per share this quarter (Q3). TCRX's actual earnings were $-0.28 per share.
TCRX EPS surprise of 7.04%Analysts estimated TCRX earnings of $-0.29 per share this quarter (Q1). TCRX's actual earnings were $-0.26 per share.
TCRX EPS surprise of 10.87%Analysts estimated TCRX earnings of $-0.28 per share this quarter (Q4). TCRX's actual earnings were $-0.30 per share.
TCRX EPS surprise of -7.45%Analysts estimated TCRX earnings of $-0.29 per share this quarter (Q3). TCRX's actual earnings were $-0.25 per share.
TCRX EPS surprise of 14.82%Analysts estimated TCRX earnings of $-0.26 per share this quarter (Q1). TCRX's actual earnings were $-0.32 per share.
TCRX EPS surprise of -22.32%Analysts estimated TCRX earnings of $-0.30 per share this quarter (Q4). TCRX's actual earnings were $-0.21 per share.
TCRX EPS surprise of 40.86%Analysts estimated TCRX earnings of $-0.46 per share this quarter (Q3). TCRX's actual earnings were $-0.24 per share.
TCRX EPS surprise of -47.94%